Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cavalli

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 1, 1989
[Dermatologic manifestations of tuberous sclerosis in children. A study of 6 cases]V Nazzaro, C Gelmetti, G Rizzitelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 10, 2022
A case of onychomadesis associated with chilblain-like lesions after COVID-19 infectionC Colonna, S Giacalone, M Zussino, et al.
Cancer Genetics and Cytogenetics|April 24, 2004
Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancerLuciane R Cavalli, Baljit Singh, Claudine Isaacs, et al.
Dermatology (Basel, Switzerland)|April 21, 2012
Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding?R Cavalli, R B Buffon, M de Souza, et al.
Cancer Genetics and Cytogenetics|January 28, 2003
Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cellsMatthew Hardwick, Luciane R Cavalli, Keith D Barlow, et al.
Breast Cancer Research and Treatment|August 22, 2009
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancerLuciane R Cavalli, Rebecca B Riggins, Antai Wang, et al.
Pharmacological Research|September 16, 2000
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsA Fundarò, R Cavalli, A Bargoni, et al.
Pharmacological Research|November 4, 2000
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic studyR Cavalli, G P Zara, O Caputo, et al.
Pharmacological Research|June 8, 2001
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distributionA Bargoni, R Cavalli, G P Zara, et al.
Pharmacological Research|September 10, 1999
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)G P Zara, R Cavalli, A Fundarò, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 1, 1989
[Dermatologic manifestations of tuberous sclerosis in children. A study of 6 cases]V Nazzaro, C Gelmetti, G Rizzitelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 10, 2022
A case of onychomadesis associated with chilblain-like lesions after COVID-19 infectionC Colonna, S Giacalone, M Zussino, et al.
Cancer Genetics and Cytogenetics|April 24, 2004
Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancerLuciane R Cavalli, Baljit Singh, Claudine Isaacs, et al.
Dermatology (Basel, Switzerland)|April 21, 2012
Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding?R Cavalli, R B Buffon, M de Souza, et al.
Cancer Genetics and Cytogenetics|January 28, 2003
Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cellsMatthew Hardwick, Luciane R Cavalli, Keith D Barlow, et al.
Breast Cancer Research and Treatment|August 22, 2009
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancerLuciane R Cavalli, Rebecca B Riggins, Antai Wang, et al.
Pharmacological Research|September 16, 2000
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsA Fundarò, R Cavalli, A Bargoni, et al.
Pharmacological Research|November 4, 2000
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic studyR Cavalli, G P Zara, O Caputo, et al.
Pharmacological Research|June 8, 2001
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distributionA Bargoni, R Cavalli, G P Zara, et al.
Pharmacological Research|September 10, 1999
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)G P Zara, R Cavalli, A Fundarò, et al.
Pageof 14